期刊文献+

N-乙酰基转移酶(NAT2)多态和肺癌遗传易感性关联研究 被引量:2

Studies on the association of NAT2 polymorphism and lung cancer genetic susceptibility
下载PDF
导出
摘要 目的探讨N-乙酰基转移酶(NAT2)和肺癌遗传易感性的关系。方法对500对医院来源的肺癌病例和对照收集其外周静脉血,提取基因组DNA后,应用illum ina分型技术对NAT2基因各功能位点进行分型,并对分型数据进行了统计学分析。结果rs7832071、rs1208(lys263 arg)的等位基因增加了肺癌的患病风险(OR=1.49,95%C I:1.04-2.13;OR=1.76,95%C I:1.21-2.55),且因二者之间的紧密连锁(R2=0.971),因此rs1208可能为一肺癌风险位点,rs7832071则可能是该风险位点的标签位点。对吸烟与否分层分析证实,在当前吸烟者中rs7832071、rs1208杂合型增加了患肺癌的风险性(OR=1.48,95%C I:1.03-2.15;OR=2.20,95%C I:1.05-4.62)。结论NAT2 rs1208(lys263 arg)为一肺癌患病风险位点。 Objective To investigate the association between N - acetyltransferase2 (NAT2) 7 functional SNPs and lung cancer genetic susceptibility. Methods Venous blood samples of 507 healthy controls and 500 lung cancer patients were collected, and genomic DNA was extracted. Illumina genotyping method was used to determined the genotype of NAT2, The genotyping results were analysed with statistic methods. Resuits Both rs 7832071 allele T and rs1208(lys263arg) allele G increased the risk of lung cancer ( OR = 1.49, 95% CI 1.04 - 2.13 ; OR = 1. 76, 95% CI 1.21 -2. 55), According to their positions in mRNA, we inferred that rs1208 might be one of the real risk SNPs in NAT2. Stratified analysis according to the smoking status proved that rs7832071 ,rs1208 could increase the risk of lung cancer in current smoker( OR = 1.48, 95% CI 1.03 -2. 15 ;OR =2.20,95%CI 1.05 -4.62). Conclusion NAT2 rs1208(lys263arg) may be one of the lung cancer risk SNPs.
出处 《临床和实验医学杂志》 2006年第11期1677-1678,1680,共3页 Journal of Clinical and Experimental Medicine
关键词 肺癌 遗传易感性 N-乙酰基转移酶 基因多态 关联研究 Lung cancer Genetic susceptibility NAT2 Polymorphism Association study
  • 相关文献

参考文献10

  • 1Seow A;Zhao B;Poh WT.NAT2 slow acetylator genotype is associated with increased risk of lung cancer among non-smoking Chinese women in Singapore[J],1999(09).
  • 2Lilla C;Verla-Tebit E;Risch A.Effect of NAT1 and NAT2 genetic polymorphisms on colorectal cancer risk associated with exposure to tobacco smoke and meat consumption[J],2006(01).
  • 3Hel OL;Peeters PH;Hein DW.NAT2 slow acetyation and GSTM1 null genotypes may increase postmenopausal breast cancer risk in long-term smoking women[J],2003(07).
  • 4高建平,黄跃东,朱青川,梁建平,林经安.N-乙酰基转移酶基因多态性与肝癌易感性的关系[J].中华肝脏病杂志,2003,11(1):20-22. 被引量:16
  • 5Wikman H;Thiel S;Jager B.Relevance of N-acetyltransferase 1 and 2 (NAT1,NAT2) genetic polymorphisms in non-small cell lung cancer susceptibility[J],2001(02).
  • 6Hamasaki T;Inatomi H;Katoh T.N-acetyltransferase-2 gene polymorphism as a possible biomarker for prostate cancer in Japanese men[J],2003(03).
  • 7Hung RJ;Boffetta P;Brennan P.GST,NAT,SULTA,CYP genetic polymorphisms,interactions with environmental exposures and bladder cancer risk in a high-risk population[J],2004(04).
  • 8Belogubova EV;Kuligina ESh;Togo AV.Comparison of extremes' approach provides evidence against the modifying role of NAT2 polymorphism in lung cancer susceptibility[J],2005(02).
  • 9梁戈玉,浦跃朴,尹立红.N-乙酰基转移酶基因多态性与肺癌易感性关系[J].中国公共卫生,2005,21(6):658-660. 被引量:6
  • 10Hein DW.Molecular genetics and function of NAT1 and NAT2:role in aromatic amine metabolism and carcinogenesis[J],2002(0).

二级参考文献13

  • 1郝钢跃,张维东,陈永和,张道新,张玉海.NAT2基因多态性与膀胱癌遗传易感性的关系[J].中华肿瘤杂志,2004,26(5):283-286. 被引量:9
  • 2WeriBS 著 徐云碧 王志宁 俞志华 译.遗传学数据分析一群体遗传学离散型数据分析方法[M].北京:中国农业出版社,1996.89-103.
  • 3Hung RJ, Boffetta P, Brennan P, et al. GST, NAT, SULT |A|, CYP |B| genetic polymorphisms, interactions with environmental exposures and bladder cancer risk in a high-risk population [J]. Int J Cancer, 2004, 110(4) :598 - 604.
  • 4Tsukino H, Kuroda Y, Nakao H, et al. Cytochrome P450(CYP)1A2, sulfotransferase (SULT) 1A1, and N - acetyltransferase (NAT) 2 polymorphisms and susceptibility to urothelial cancer[J]. J Cancer Res Clin Oncol, 2004, 130(2):99- 106.
  • 5Hamasaki T, Inatomi H, Katoh T, et al. N - acetyltransferase - 2gene polymorphism as a possible biomarker for prostate cancer in Japanese men[J]. Int J Urol, 2003,10(3): 167 - 173.
  • 6Hel OL, Peeters PH, Hein DW, et al. NAT2 slow acetyation and GSTM1 null genotypes may increase postmenopausal breast cancer risk in long- term smoking women [J]. Pharmacogenetics, 2003, 13(7) :399 - 407.
  • 7Hou SM, Ryberg D, Falt S, et al. GSTM1 and NAT2 polymorphisms in operable and non- operable lung cancer patients[J]. Carcinogenesis, 2000, 21(1): 49 - 54.
  • 8Seow A, Zhao B, Poh WT, et al. NAT2 slow acetylator genotype is associated with increased risk of lung cancer among non - smoking Chinese women in Singapore[J]. Carcinogenesis, 1999, 20 (9): 1877- 1881.
  • 9Cascorbi I, Brockmoller J, Mrozikiewicz PM, et al. Homozygous rapid arylamine N- acetyltransferase (NAT2) genotype as a susceptibility factor for lung cancer[J]. Cancer Res, 1996, 56(17) :3961 - 3966.
  • 10Wikman H, Thiel S, Jager B, et al. Relevance of N - acetyltransferase 1 and 2 (NAT1, NAT2) genetic polymorphisms in non - small cell lung cancer susceptibility[J]. Pharmacogenetics, 2001, 11 (2): 157 -168.

共引文献19

同被引文献19

  • 1Covolo L, Plaeidi D, Gelatti U, et al. Bladder cancer, GSTs, NAT1, NAT2, SULT1A1, XRCC1, XRCC3, XPD genetic polymorphisrns and coffee consumption: a case-control study. Eur J Epidemiol, 2008, 23: 355-362.
  • 2Liu HE, Hsiao PY, Lee CC, el al. NAT2*7 allele is a potential risk factor for adult brain tumors in Talwanese population. Cancer Epidemiol Biomarkers Prey, 2008, 17: 661-665.
  • 3Delort L, Chalabi N, Satih S, et al. Association between genetic polymorphisms and ovarian cancer risk. Anticancer Res, 2008, 28: 3079-3081.
  • 4Lang NP, Chu DZ, Hunter CF, et al. Role of aromatic amine acetyltransferase in human colorectal cancer. Arch Surg, 1986, 121: 1259-1261.
  • 5Moslehi R, Chalterjee N, Church TR, ct al. Cigarette smoking, N- acetyltransferase genes and the risk of advanced cotorectal adenoma. Pharmacogenomics, 2006, 7:819-829.
  • 6Huang CC, Chien WP, Wong RH, et al. NAT2 fast acetylator genotype is associated with an increased risk af colorectal cancer in Taiwan. Dis Calon Rectum, 2007, 50:981-989.
  • 7Kiss I, N e meth A, Bogner B, et al. Polymorphisms of glutathione-S- transferase and arylamine N-acetyltransferase enzymes and susceptibility to colorectal cancer. Anlicancer Res, 2004, 24: 3965- 3970.
  • 8Ye Z, Parry JM. Meta-analysis of 20 case-control studies on the N- acctyhransferase 2 acelylation status and coloreetal cancer risk. Med Sei Monit, 2002, 8: CR558-565.
  • 9Windmill KF, Gaedigk A, Hall PM, et al. Localization of N- acetyltransferases NAT1 and NAT2 in human tissue. Toxicol Sci, 2000, 54: 19-29.
  • 10HEIN D W, DOLL M A, FRETLAND A J, et al. Molecular ge- netics and epidemiology of the NAT1 and NAT2 acetylation poly- morphisms[ Jl. Cancer Epidemiol Biomarkers Prey, 2000, 9( 1 ) : 29 - 42.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部